B. Riley Securities initiated coverage on Wave Life Sciences with a new price target
$WVE
Biotechnology: Pharmaceutical Preparations
Health Care
B. Riley Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $11.00